Which EU countries are calling for a unified pharmaceutical pricing framework?

Belgium, the Netherlands, Luxembourg, Austria, and Ireland jointly urged the EU to develop a unified approach to pharmaceutical regulation and pricing. Their move responds to U.S. drug pricing pressures and aims to strengthen the bloc’s negotiation leverage and consistency in price-setting across member states.